CRIS Q2 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+15.9% YoY

Gross Profit

$3M99.5% margin

Operating Income

-$13M-491.4% margin

Net Income

-$12M-463.6% margin

EPS (Diluted)

$-2.03

QoQ Revenue Growth

+22.1%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$50M

Total Liabilities

$51M

Stockholders' Equity

-$694,000

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+15.9%
Gross Profit	$3M	$2M	+19.4%
Operating Income	-$13M	-$12M	-3.1%
Net Income	-$12M	-$12M	+1.3%